TrialBMC musculoskeletal disorders2014

Comparison of the efficacy and safety profiles of a pelubiprofen versus celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, phase III, non-inferiority clinical trial.

In Ah Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.